Evidence map›Paper›PMID 30634982›Full record

ArticleJournal of translational medicine2019

Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α.

Immacolata Maida, Paola Zanna, Stefania Guida, Anna Ferretta, Tiziana Cocco, Luigi Leonardo Palese, Paola Londei, Dario Benelli, Amalia Azzariti, Stefania Tommasi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Immacolata MaidaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Paola ZannaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Stefania GuidaDermatology Unit, Department of Surgical, Medical, Dental and Morphological Science with Interest Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy. drstefaniaguida@gmail.com.
Anna FerrettaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Tiziana CoccoDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Luigi Leonardo PaleseDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Paola LondeiDepartment of Cellular Biotechnology and Hematology BCE, Sapienza University of Rome, Rome, Italy.
Dario BenelliDepartment of Cellular Biotechnology and Hematology BCE, Sapienza University of Rome, Rome, Italy.
Amalia AzzaritiNational Cancer Research Centre "Giovanni Paolo II", Bari, Italy.
Stefania TommasiNational Cancer Research Centre "Giovanni Paolo II", Bari, Italy.
Michele GuidaNational Cancer Research Centre "Giovanni Paolo II", Bari, Italy.
Giovanni PellacaniDermatology Unit, Department of Surgical, Medical, Dental and Morphological Science with Interest Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Gabriella GuidaDepartment of Basic Medical Sciences Neurosciences and Sense Organs, University of Bari, Bari, Italy. gabriella.guida@uniba.it.
University of Bari Aldo Moro · ITIstituto Tumori Bari · ITSapienza University of Rome · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelanoma cells develop adaptive responses in order to cope with particular conditions of tumor microenvironment, characterized by stress conditions and deregulated proliferation. Recently, the interplay between the stress response and the gene expression programs leading to metastatic spread has been reported.

methodsWe evaluated levels and localization of eIF2α/peIF2α in V600BRAF and wtBRAF metastatic melanoma cell lines by means of western blot and confocal microscopy analyses. Furthermore, we performed a sequence analyses and structure and dynamics studies of eIF2α protein to reveal the role of eIF2α and its correlations in different pathways involved in the invasive phase of melanoma.

resultsWe found peIF2α both in cytoplasm and nucleus. Nuclear localization was more represented in V600BRAF melanoma cell lines. Our studies on eIF2α protein sequence indicated the presence of a predicted bipartite NLS as well as a nuclear export signal NES and an S1 domain, typical of RNA interacting proteins. Furthermore, we found high levels of transcription factor EB (TFEB), a component of the MiT/TFE family, and low β-catenin levels in V600BRAF cells.

conclusionsBased on our results, we suggest that peIF2α nuclear localization can be crucial in ER stress response and in driving the metastatic spread of melanoma, through lysosomal signaling and Wnt/β-catenin pathway. In conclusion, this is the first evidence of nuclear localization of peIF2α, representing a possible target for future therapeutic approaches for metastatic melanoma.

Indexed as

Protein BiosynthesisAmino Acid SequenceBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsbeta CateninCell Line, TumorCutaneous Malignant MelanomaEukaryotic Initiation Factor-2HumansMelanomaPhosphorylationProtein SubunitsSkin NeoplasmsBasic Helix-Loop-Helix Leucine Zipper Transcription Factorsbeta CateninEukaryotic Initiation Factor-2Protein SubunitsTFEB protein, humanBRAFeIF2αMetastatic melanomaMiT familyNuclear peIF2αStructural analysis

Identifiers

PMID30634982
PMCPMC6329103
OpenAlexW2914427210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.